Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
4.82 USD | -0.82% | +1.46% | -45.03% |
Kurzporträt
Mitarbeiterzahl: 234
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 70 | 01.07.20 | |
Allan Reine
DFI | Director of Finance/CFO | 49 | 17.01. |
Chief Operating Officer | 52 | 01.09.22 | |
Jeremy Duffield
CTO | Chief Tech/Sci/R&D Officer | 55 | 01.01.21 |
Ann Lee
CTO | Chief Tech/Sci/R&D Officer | 62 | 01.10.21 |
Mohammed Asmal
CTO | Chief Tech/Sci/R&D Officer | - | - |
Fubao Wang
LAW | General Counsel | - | - |
Karen Brown
LAW | General Counsel | - | - |
Niamh Alix
HRO | Human Resources Officer | - | 01.06.22 |
Carman Alenson
AUD | Comptroller/Controller/Auditor | 58 | 01.08.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 64 | 01.12.21 | |
Robert Nelsen
BRD | Director/Board Member | 60 | 01.09.20 |
Michael Kelly
BRD | Director/Board Member | 67 | 01.11.21 |
David Schenkein
BRD | Director/Board Member | 66 | 13.09.19 |
Chief Executive Officer | 70 | 01.07.20 | |
Director/Board Member | 46 | 10.05.23 | |
Thomas Cahill
BRD | Director/Board Member | 37 | 01.11.21 |
Wendy Chung
BRD | Director/Board Member | 55 | 01.11.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 119 939 247 | 89 931 997 ( 74,98 %) | 0 | 74,98 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-45.03% | 560 Mio. | |
-2.84% | 102 Mrd. | |
+1.91% | 96.29 Mrd. | |
+1.86% | 22.18 Mrd. | |
-15.21% | 21.2 Mrd. | |
-9.07% | 18.31 Mrd. | |
-39.98% | 17.38 Mrd. | |
-14.12% | 16.36 Mrd. | |
+5.36% | 13.97 Mrd. | |
+32.51% | 12.17 Mrd. |
- Börse
- Aktien
- A3DW68 Aktie
- Unternehmen Prime Medicine, Inc.